A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 159 participants.
Also called NCT02750410
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 159 participants
- Sponsor
- Registry
-
NCT02750410
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02750410. Randomized; double masking; primary purpose treatment. Start 2016-08 (registry gives no type); primary completion 2018-06-18 (actual). Results posted on 2019-09-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Dulaglutide in Japanese Participants With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Dulaglutide
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct02750410- Content hash
e8d6c930c6679db7af5904231dca29fb52454cf3a31171e4dbe316e23b507745